Marcus Gerlach

Planegg, BY, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

TUB-040, a Homogeneous and Hydrophilic NaPi2b-Targeting ADC with Stably Linked Exatecan, Exhibits Long-lasting Antitumor Activity and a Well-Tolerated Safety Profile.

TUB-040, a Homogeneous and Hydrophilic NaPi2b-Targeting ADC with Stably Linked Exatecan, Exhibits Long-lasting Antitumor Activity and a Well-Tolerated Safety Profile.

Journal: Molecular cancer therapeutics

Published: March 06, 2025

TUB-010, a novel anti-CD30 antibody-drug conjugate based on Tub-tag technology, widens the therapeutic window by reducing toxicity while maintaining high efficacy.

TUB-010, a novel anti-CD30 antibody-drug conjugate based on Tub-tag technology, widens the therapeutic window by reducing toxicity while maintaining high efficacy.

Journal: Molecular cancer therapeutics

Published: January 21, 2025

Design and Evaluation of Phosphonamidate-Linked Exatecan Constructs for Highly Loaded, Stable, and Efficacious Antibody-Drug Conjugates.

Design and Evaluation of Phosphonamidate-Linked Exatecan Constructs for Highly Loaded, Stable, and Efficacious Antibody-Drug Conjugates.

Journal: Molecular cancer therapeutics

Published: June 10, 2023

Targeting FLT3 with a new-generation antibody-drug conjugate in combination with kinase inhibitors for treatment of AML.

Targeting FLT3 with a new-generation antibody-drug conjugate in combination with kinase inhibitors for treatment of AML.

Journal: Blood

Published: December 21, 2021

Site-Specific Conjugation Strategy for Dual Antibody-Drug Conjugates Using Aerobic Formylglycine-Generating Enzymes.

Site-Specific Conjugation Strategy for Dual Antibody-Drug Conjugates Using Aerobic Formylglycine-Generating Enzymes.

Journal: Bioconjugate chemistry

Published: June 01, 2021

Site-Specific Antibody Fragment Conjugates for Reversible Staining in Fluorescence Microscopy.

Site-Specific Antibody Fragment Conjugates for Reversible Staining in Fluorescence Microscopy.

Journal: Chembiochem : a European journal of chemical biology

Published: October 21, 2020

N-Hydroxysuccinimide-Modified Ethynylphosphonamidates Enable the Synthesis of Configurationally Defined Protein Conjugates.

N-Hydroxysuccinimide-Modified Ethynylphosphonamidates Enable the Synthesis of Configurationally Defined Protein Conjugates.

Journal: Chembiochem : a European journal of chemical biology

Published: September 20, 2019

Tubulin Tyrosine Ligase-Mediated Modification of Proteins.

Tubulin Tyrosine Ligase-Mediated Modification of Proteins.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: June 05, 2019

Ethynylphosphonamidates for the Rapid and Cysteine-Selective Generation of Efficacious Antibody-Drug Conjugates.

Ethynylphosphonamidates for the Rapid and Cysteine-Selective Generation of Efficacious Antibody-Drug Conjugates.

Journal: Angewandte Chemie (International ed. in English)

Published: April 05, 2019

TuPPL: Tub-tag mediated C-terminal protein-protein-ligation using complementary click-chemistry handles.

TuPPL: Tub-tag mediated C-terminal protein-protein-ligation using complementary click-chemistry handles.

Journal: Organic & biomolecular chemistry

Published: April 02, 2019

Two-fold Bioorthogonal Derivatization by Different Formylglycine-Generating Enzymes.

Two-fold Bioorthogonal Derivatization by Different Formylglycine-Generating Enzymes.

Journal: Angewandte Chemie (International ed. in English)

Published: March 15, 2018

Showing 1-11 of 11

Last Updated: 09/26/2026